I know Mayne have stated they expect this to be FDA approved and to market during FY19, but do we have any idea either how this is progressing or what the standard timeframes are for a product to be reviewed within once submitted?
- Forums
- ASX - By Stock
- MYX
- Nuvaring generic
MYX
mayne pharma group limited
Add to My Watchlist
1.57%
!
$5.00

Nuvaring generic
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
-0.080(1.57%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.08 | $5.10 | $4.95 | $1.426M | 285.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.02 | 259 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7653 | 4.960 |
2 | 971 | 4.940 |
1 | 753 | 4.930 |
1 | 753 | 4.910 |
2 | 12000 | 4.900 |
Price($) | Vol. | No. |
---|---|---|
5.020 | 259 | 1 |
5.060 | 256 | 1 |
5.070 | 753 | 1 |
5.090 | 251 | 1 |
5.100 | 7653 | 5 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |